Advertisement
Screener

4D Molecular Therapeutics, Inc. (FDMT) Net Margin

4D Molecular Therapeutics, Inc. (FDMT) Net Margin

  • 2026-06-30: Net Margin -1929.01%.
  • 2026-03-31: Net Margin -2256.65%.
  • 2025-12-31: Net Margin 22.80%.
  • 2025-09-30: Net Margin -63195.56%.

Complete source-backed net margin history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-1929.01%
2026-03-31-2256.65%
2025-12-3122.80%
2025-09-30-63195.56%
2025-06-30-364386.67%
2025-03-31-342657.14%
2024-12-31-4967100.00%
2024-09-30-1461433.33%
2024-06-30-699060.00%
2024-03-31-115717.86%
2023-12-31169910.53%
2023-09-30-50.76%
2023-06-30-12391.63%
2023-03-31-9624.83%
2022-12-31-2195.59%
2022-09-30-5138.20%
2022-06-30-17337.04%
2022-03-31-2160.62%
2021-12-31-27264.13%
2021-09-30-1628.04%
2021-06-30-52.05%
2021-03-31-820.30%
2020-12-312103.07%
2020-09-30-105.55%
2020-06-30-431.96%
2020-03-31-385.81%

Annual Net Margin

DateNet Margin
2025-12-31-164.43%
2024-12-31-434778.38%
2023-12-31-486.59%
2022-12-31-3435.41%
2021-12-31-395.37%
2020-12-31-424.25%
2019-12-31-708.42%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Entera Bio Ltd. (ENTX)$0.485B